Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Aug;92(2):978–983. doi: 10.1172/JCI116674

The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/alpha 2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin.

M D Kramer 1, J Reinartz 1
PMCID: PMC294938  PMID: 7688770

Abstract

Plasminogen activators produced locally in the skin have been implicated in blistering skin diseases. To explore whether plasminogen activators convert their substrate plasminogen into plasmin locally in the lesional skin we have analyzed the autoimmune blistering skin disease bullous pemphigoid. Enzyme activity was detected in bullous pemphigoid skin blister fluid by using a low molecular weight chromogenic substrate for plasmin. Enzyme activity was detected neither in suction blister fluid raised on normal skin nor in normal plasma. Immunoprecipitation or fractionation by molecular sieve chromatography of bullous pemphigoid skin blister fluid followed by testing in immunoassays disclosed putative plasmin/alpha 2-macroglobulin complexes and plasmin/alpha 2-antiplasmin complexes. Enzyme activity detected in bullous pemphigoid skin blister fluid by the low molecular weight chromogenic peptide assay was ascribed to the putative plasmin pha 2-macroglobulin complexes. Because formation of plasmin-inhibitor complexes requires the active plasmin, our findings indicate previous activation of plasminogen to plasmin in skin lesions. There was no evidence for free plasmin (i.e., plasmin not complexed to inhibitors) in bullous pemphigoid blister fluid, suction blister fluid, or plasma.

Full text

PDF
978

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baird J., Lazarus G. S., Belin D., Vassalli J. D., Busso N., Gubler P., Jensen P. J. mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis. J Invest Dermatol. 1990 Nov;95(5):548–552. doi: 10.1111/1523-1747.ep12504901. [DOI] [PubMed] [Google Scholar]
  2. Brunner G., Schirrmacher V. Fibrin autography of plasminogen activator by electrophoretic transfer into fibrin agar gels. Anal Biochem. 1988 Feb 1;168(2):411–416. doi: 10.1016/0003-2697(88)90337-5. [DOI] [PubMed] [Google Scholar]
  3. Burge S. M., Marshall J. M., Cederholm-Williams S. A. Plasminogen binding sites in normal human skin. Br J Dermatol. 1992 Jan;126(1):35–41. doi: 10.1111/j.1365-2133.1992.tb08400.x. [DOI] [PubMed] [Google Scholar]
  4. Collen D. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture. Thromb Haemost. 1980 Jun 18;43(2):77–89. [PubMed] [Google Scholar]
  5. Danø K., Andreasen P. A., Grøndahl-Hansen J., Kristensen P., Nielsen L. S., Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res. 1985;44:139–266. doi: 10.1016/s0065-230x(08)60028-7. [DOI] [PubMed] [Google Scholar]
  6. Del Rosso M., Fibbi G., Dini G., Grappone C., Pucci M., Caldini R., Magnelli L., Fimiani M., Lotti T., Panconesi E. Role of specific membrane receptors in urokinase-dependent migration of human keratinocytes. J Invest Dermatol. 1990 Mar;94(3):310–316. doi: 10.1111/1523-1747.ep12874442. [DOI] [PubMed] [Google Scholar]
  7. Farmer E. R. Subepidermal bullous diseases. J Cutan Pathol. 1985 Jun-Aug;12(3-4):316–321. doi: 10.1111/j.1600-0560.1985.tb01635.x. [DOI] [PubMed] [Google Scholar]
  8. Friberger P. Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems. Scand J Clin Lab Invest Suppl. 1982;162:1–298. [PubMed] [Google Scholar]
  9. Gissler H. M., Simon M. M., Kramer M. D. Enhanced association of plasminogen/plasmin with lesional epidermis of bullous pemphigoid. Br J Dermatol. 1992 Sep;127(3):272–277. doi: 10.1111/j.1365-2133.1992.tb00127.x. [DOI] [PubMed] [Google Scholar]
  10. Isseroff R. R., Rifkin D. B. Plasminogen is present in the basal layer of the epidermis. J Invest Dermatol. 1983 Apr;80(4):297–299. doi: 10.1111/1523-1747.ep12534677. [DOI] [PubMed] [Google Scholar]
  11. Jensen P. J., Baird J., Morioka S., Lessin S., Lazarus G. S. Epidermal plasminogen activator is abnormal in cutaneous lesions. J Invest Dermatol. 1988 Jun;90(6):777–782. doi: 10.1111/1523-1747.ep12461494. [DOI] [PubMed] [Google Scholar]
  12. Justus C., Müller S., Kramer M. D. A monoclonal antibody recognizing plasminogen and plasmin--altered reactivity in psoriatic lesions. Br J Dermatol. 1987 Dec;117(6):687–694. doi: 10.1111/j.1365-2133.1987.tb07347.x. [DOI] [PubMed] [Google Scholar]
  13. Lauharanta J., Salonen E. M., Vaheri A. Plasmin-like proteinase associated with high molecular weight complexes in blister fluid of bullous pemphigoid. Acta Derm Venereol. 1989;69(6):527–529. [PubMed] [Google Scholar]
  14. McNeill H., Jensen P. J. A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration. Cell Regul. 1990 Oct;1(11):843–852. doi: 10.1091/mbc.1.11.843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Meissauer A., Kramer M. D., Schirrmacher V., Brunner G. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro. Exp Cell Res. 1992 Apr;199(2):179–190. doi: 10.1016/0014-4827(92)90423-6. [DOI] [PubMed] [Google Scholar]
  16. Plow E. F., Freaney D. E., Plescia J., Miles L. A. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol. 1986 Dec;103(6 Pt 1):2411–2420. doi: 10.1083/jcb.103.6.2411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pöllänen J., Stephens R., Salonen E. M., Vaheri A. Proteolytic mechanisms operating at the surface of invasive cells. Adv Exp Med Biol. 1988;233:187–199. doi: 10.1007/978-1-4899-5037-6_21. [DOI] [PubMed] [Google Scholar]
  18. Raum D., Marcus D., Alper C. A., Levey R., Taylor P. D., Starzl T. E. Synthesis of human plasminogen by the liver. Science. 1980 May 30;208(4447):1036–1037. doi: 10.1126/science.6990488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Saksela O. Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta. 1985 Nov 12;823(1):35–65. doi: 10.1016/0304-419x(85)90014-9. [DOI] [PubMed] [Google Scholar]
  20. Singer K. H., Sawka N. J., Samowitz H. R., Lazarus G. S. Proteinase activation: a mechanism for cellular dyshesion in pemphigus. J Invest Dermatol. 1980 May;74(5):363–367. doi: 10.1111/1523-1747.ep12543780. [DOI] [PubMed] [Google Scholar]
  21. Spillman D. H., Magnin P. H., Roquel L., Mitsui M. Aprotinin inhibition of experimental pemphigus in Balb-c mice following passive transfer of pemphigus foliaceus serum. Clin Exp Dermatol. 1988 Sep;13(5):321–327. doi: 10.1111/j.1365-2230.1988.tb00714.x. [DOI] [PubMed] [Google Scholar]
  22. Stephens R. W., Pöllänen J., Tapiovaara H., Leung K. C., Sim P. S., Salonen E. M., Rønne E., Behrendt N., Danø K., Vaheri A. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J Cell Biol. 1989 May;108(5):1987–1995. doi: 10.1083/jcb.108.5.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Takamori K., Yoshiike T., Morioka S., Ogawa H. The role of proteases in the pathogenesis of bullous dermatoses. Int J Dermatol. 1988 Oct;27(8):533–539. doi: 10.1111/j.1365-4362.1988.tb02399.x. [DOI] [PubMed] [Google Scholar]
  24. Travis J., Salvesen G. S. Human plasma proteinase inhibitors. Annu Rev Biochem. 1983;52:655–709. doi: 10.1146/annurev.bi.52.070183.003255. [DOI] [PubMed] [Google Scholar]
  25. Volden G. Acid hydrolases in blister fluid. 3. Characterization and quantification of peptide hydrolases. Br J Dermatol. 1978 Jul;99(1):49–52. doi: 10.1111/j.1365-2133.1978.tb01960.x. [DOI] [PubMed] [Google Scholar]
  26. Wiman B., Collen D. On the mechanism of the reaction between human alpha 2-antiplasmin and plasmin. J Biol Chem. 1979 Sep 25;254(18):9291–9297. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES